Home›Stock Screener›Vilin Bio Med›Financial Statements

Vilin Bio Med Complete Financial Statements

7 Years of Data
2026 - 2020

In FYNone, Vilin Bio Med (VILINBIO) reported revenue ₹8 Cr, net profit ₹1 Cr and EPS ₹2.20, with a net profit margin of 4.8% and ROE of 7.1%. Full financial statements from FY2020 to FY2026 (7 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse VILINBIO FII DII holdings to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 4.76% 2026 data
EBITDA Margin 7.14% 2026 data
Operating Margin 8.00% 2026 data
Return on Assets 5.71% 2026 data
Return on Equity 7.14% 2026 data

Balance Sheet Ratios

Equity Ratio 80.00% 2026 data
Asset Turnover 1.20 2026 data

VILINBIO Revenue, Net Profit & EBITDA — Year-on-Year Growth

VILINBIO YoY (March 2026 vs Period) — revenue -81.0%, net profit -50.0%, EBITDA -33.3%, expenses -82.1%. For live price, earnings ratios and company overview, see Vilin Bio Med share price chart.

Revenue Growth
-81.0%
Year-over-Year
Net Profit Growth
-50.0%
Year-over-Year
EBITDA Growth
-33.3%
Year-over-Year
Expense Growth
-82.1%
Year-over-Year
Assets Growth
+25.0%
Year-over-Year
Equity Growth
+21.7%
Year-over-Year
Operating Cash Flow Growth
+100.0%
Year-over-Year
Financing Cash Flow Growth
-155.6%
Year-over-Year

VILINBIO Income Statement — Revenue, EBITDA & Net Profit

Vilin Bio Med revenue ₹8 Cr, EBITDA ₹2 Cr, net profit ₹1 Cr, EPS ₹2.20 (None) — net profit margin 4.8%. Also explore VILINBIO price movement history to track price trends across different timeframes.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Revenue 8 42 15 16 12 11 12 17
Expenses 7 39 14 15 10 10 11 16
EBITDA 2 3 1 1 3 1 1 1
Operating Profit Margin % 8.00% 8.00% 5.00% 5.00% 21.00% 7.00% 7.00% 5.00%
Depreciation 0 0 0 0 0 0 0 0
Interest 0 0 1 1 1 1 0 0
Profit Before Tax 1 3 0 0 2 0 0 0
Tax 0 1 0 0 1 0 0 0
Net Profit 1 2 0 0 1 0 0 0
Earnings Per Share (₹) 2.20 1.37 0.16 0.12 1.25 0.10 0.15 0.20

VILINBIO Balance Sheet — Assets, Liabilities & Shareholders' Equity

VILINBIO total assets ₹35 Cr, total equity ₹28 Cr, total liabilities ₹ Cr (2026) — ROE 7.1%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 35 28 32 18 14 14 14
Current Assets 27 13 19 8 12 12 12
Fixed Assets 3 1 1 2 2 2 2
Capital Work in Progress 0 2 0 0 0 0 0
Investments 7 0 0 0 0 0 0
Other Assets 0 25 31 16 12 12 12
LIABILITIES
Total Liabilities
Current Liabilities 0 0 0 1 1 1 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 28 23 23 11 7 7 7
Share Capital 15 14 14 10 3 3 3
Reserves & Surplus 13 9 9 1 4 4 4

VILINBIO Cash Flow Statement — Operating, Investing & Financing

Vilin Bio Med operating cash flow ₹0 Cr, investing ₹-1 Cr, financing ₹-5 Cr, net cash flow ₹-6 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Operating Activities 0 -7 -2 0 -1 -2
Investing Activities -1 0 0 0 0 0
Financing Activities -5 9 2 0 1 2
Net Cash Flow -6 2 0 0 0 0